The Study
THE PREVALENCE AND ASSOCIATED RISK FACTORS OF REBOUND HYPERTHYROIDISM IN GRAVES’ DISEASE AFTER ANTI-THYROID DRUG DOSE REDUCTION (PARAGON STUDY)
This study looked back at patients who already had rebound hyperthyroidism and compared them to those who didn’t, to see what things were different. It found some patterns, like people who took beta-blockers were more likely to have rebound, but that doesn’t mean the beta-blockers caused it — maybe sicker people were more likely to get beta-blockers in the first place.
Analysis score
Maximum 58 for a case-control study.
Where the score came from
Some people with an overactive thyroid take medicine to calm it down. When doctors lower the medicine dose, sometimes the thyroid gets too active again.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 554 / 100
Quality score
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Key takeaways
Summary
Based on the study abstract and findings.
- 1A 12% chance of relapse means about 1 in 8 patients may need higher medicine again — a meaningful risk for doctors and patients planning treatment.
- 212 out of 100 patients got hyperthyroidism again after their medicine was lowered.
- 3Three things made it more likely: using beta-blockers, having very high thyroid hormone levels at first, and having very low TSH when medicine was reduced.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Journal of the ASEAN Federation of Endocrine Societies
Year
2023
Authors
Papanun Mahapol
Related Content
Claims (3)
Anti-thyroid medications lower the amount of thyroid hormones produced by the thyroid gland.
Thyroid hormone modulation therapy lowers the clinical symptoms of Graves disease by bringing hormone levels back to normal ranges.
Anti-thyroid medications lower thyroid hormone levels and lead to sustained reduction in autoimmune damage to the thyroid in people with Graves' disease.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.